Valiant Laboratories Limited (NSE:VALIANTLAB)
India · Delayed Price · Currency is INR 56.10
-0.84 (-1.48%)
Apr 2, 2026, 3:29 PM IST
Valiant Laboratories Market Cap
Valiant Laboratories has a market cap or net worth of 3.09 billion as of April 2, 2026. Its market cap has decreased by -13.59% in one year.
Market Cap
3.09B
Enterprise Value
3.00B
Revenue
2.03B
Ranking
n/a
PE Ratio
n/a
Stock Price
56.10
Market Cap Chart
Since October 6, 2023, Valiant Laboratories's market cap has decreased from 7.40B to 3.09B, a decrease of -58.19%. That is a compound annual growth rate of -29.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 3.09B | -18.66% |
| Dec 31, 2025 | 3.80B | -21.26% |
| Dec 31, 2024 | 4.83B | -35.84% |
| Dec 29, 2023 | 7.53B | 1.73% |
| Oct 6, 2023 | 7.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jagsonpal Pharmaceuticals | 12.32B |
| Beta Drugs | 12.01B |
| Ind-Swift Laboratories | 11.40B |
| Sakar Healthcare | 11.09B |
| Sigachi Industries | 6.47B |
| Bafna Pharmaceuticals | 2.59B |
| Nectar Lifesciences | 1.81B |
| Brooks Laboratories | 1.09B |